Association of Cytochrome P-450 Polymorphism with adverse clinical outcomes among Patients with Ischemic Stroke: Pragmatic and Preliminary study
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0000354
- Lead Sponsor
- Hallym University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 163
Inclusion Criteria
1. Ischemic stroke survivor on clopidogrel therapy
- Patients who survived a first ischemic stroke were exposed to clopidogrel in Hallym university Sacred Heart Hospital
- Patients who continuously taken clopidogrel for secondary prevention of stroke
2. CYP2C19 genotyping
- Patients who underwent CYP2C19 genotyping.
3. Informed consent
Exclusion Criteria
none
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cardiovascular event (ischemic storke, hemorrhagic stroke, MI, unstable angina)
- Secondary Outcome Measures
Name Time Method